About us

 

Heritage as part of the future

In May 2010 Ferrosan Medical Devices A/S was demerged from Ferrosan A/S and established its own legal entity. Ferrosan A/S's engagement in the haemostatic area dates back to 1947 when the company developed and launched its first product, the absorbable gelatin sponge SPONGOSTAN™.

The absorbable gelatin sponge was CE marked approved as medical device in 1996 and FDA PMA approved in 1999.

It is the extensive knowledge of more than 70 years that is the heritage of the company upon which the future is being built with the development of advanced haemostatic agent products. Today the company is a world leading provider of gelatin-based topical absorbable haemostatic agent products.

Since June 2016 Ferrosan Medical Devices A/S has been owned by a consortium of private Nordic investors. 

 

We do what we do best

Ferrosan Medical Devices A/S has strong capabilities within Operations and Technology Development. Being a business development and manufacturing house and focus on these activities within the value chain, we strongly believe that this is where we best utilize our capabilities and provide added value to our distribution partners but foremost to the surgeons and nurses who uses our products in critical surgical settings.

We are more than 140 employees divided into operations and development. Our headquarters are located in Soeborg, close to Copenhagen, where we have production, laboratories, administration, business development, research & development, engineering, regulatory affairs, quality assurance, supply chain and sales & marketing.